Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-031358
Filing Date
2006-05-19
Accepted
2006-05-19 12:35:44
Documents
1
Period of Report
2006-05-17

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bos20827_bos1alb.html 4  
1 MAIN DOCUMENT DESCRIPTION bos20827_bos1alb.xml 4 2900
  Complete submission text file 0001209191-06-031358.txt   4569
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Issuer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22322 20TH AVENUE SE STE 150 BOTHELL WA 98021
Business Address
BOYNTON ALTON L (Reporting) CIK: 0001253935 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-33393 | Film No.: 06854361